CANESTEN HYDROCORTISONE ATHLETES FOOT

Posology:

Adults, elderly and children age 10 years and over: Canesten Hydrocortisone should be thinly and evenly applied to the affected area twice daily and rubbed in gently. The maximum period of treatment is seven days. A total daily dose of 10 mg cream per kg body weight should not be exceeded.

For an adult weighing 50 kg the maximum daily dose is 500 mg cream which equals approximately 2 cm of cream to be divided into 2 applications per day.

Treatment duration:

If the acute symptoms have subsided after about 7 days but treatment is still required, this may be carried out with the corticoid-free preparation intended for this purpose.

As the listed undesirable effects are based on spontaneous reports, assigning accurate frequency of occurrence for each is not possible Immune system disorders: allergic reaction (syncope, hypotension, dyspnea, urticaria). 4) After use on large areas (more than 10% of the body surface) and/or after long- term use (longer than 2-4 weeks) or use under occlusive dressings, local skin alterations such as skin atrophy, teleangiectasias, hypertrichosis, striations, hypopigmentation, secondary infection and acneiform symptoms may occur.

Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Because of its corticosteroid content, Canesten Hydrocortisone should not be applied: • To large areas (more than 5 - 10% of the body surface). • In long term continuous therapy. • Under occlusive dressings (such as nappies and bandages).

These restrictions apply particularly in children, where increased systemic absorption may occur resulting in adrenocortical suppression. g. contact dermatitis). The cream also contains benzyl alcohol which may cause allergic reactions and mild local irritation.

Visual disturbance:

Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.

1 • Use on broken skin. • Use on large areas of skin. • Use for periods of longer than seven days. • To treat cold sores or acne. • Use on the face, eyes, mouth or mucous membranes. • Children under 10 years of age, unless prescribed by a doctor.

• Pregnancy and lactation, unless prescribed by a doctor. • Use on the ano-genital area, unless prescribed by a doctor. • To treat ringworm, unless prescribed by a doctor. • To treat secondarily infected skin conditions, unless prescribed by a doctor.

g. g. ) • Dermal vaccination reactions.